Q4 2025 earnings call highlights: 2026 revenue outlook, Bako/StrataDx deals, AI pathology gains, and customer-loss risks—read now.

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

Investigators in the Nancy Guthrie case have turned to genetic genealogy as they try to make the most of potential DNA ...

A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced a concept that could reshape how psychiatrists and geneticists think about mental illness: genetic specificity. Led by ...

In Q3, these efforts continued to pay off as revenue growth accelerated for a third consecutive quarter. Given the strong performance and the accelerating momentum we are seeing across the business, ...

As hopeful parents start their reproductive journeys, they may be offered a variety of tests and screenings, which can be ...

They could be the biological parents of a baby girl born in December to a Brevard County couple, who, after IVF, gave birth to a child who is not biologically theirs.

From everyday curiosities to mind-bending mysteries, here are 25 questions everyone wants answered. Prepare to discover what you’ve been wondering.

Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 ...

Massive Swedish study of over two million people reveals that genetic risk for mental illness often points toward ...

Veteran adman Prabhakar Mundkur explains how performance-based remuneration aligns incentives, but it also redistributes risk ...

Q4 2025 earnings call recap: revenue beat, MyRisk/GeneSight growth, 2026 guidance, new test launches & key risks—read now.